
Moderna ETFs to Rally on Two-in-One Vaccine Booster Shot News
Published on September 12, 2021
Moderna is expected to gain on approval for booster shots and new positive data on its COVID-19 vaccine.

Moderna is expected to gain on approval for booster shots and new positive data on its COVID-19 vaccine.